Abstract |
TP-110, a novel proteasome inhibitor, has been found to possess potent growth inhibition in human multiple myeloma cells. To enhance its therapeutic effects, we established TP-110-resistant RPMI-8226 (RPMI-8226/ TP-110) cells and elucidated their resistance mechanisms. The IC₅₀ value for TP-110 cytotoxicity in the RPMI-8226/ TP-110 cells was about 10-fold higher than that of the parental sensitive cells. The RPMI-8226/ TP-110 cells exhibited distinct drug resistance to other proteasome inhibitors. Furthermore, they showed high cross-resistance to the cytotoxic effects of doxorubicin, etoposide, taxol, and vincristine. P-glycoprotein (MDR1), encoded by ABCB1, was elevated in the RPMI-8226/ TP-110 cells, and the MDR1 inhibitor verapamil overcame their resistance to TP-110. The results of DNA microarray and RT-PCR suggested that the expression of ABCB1 is significantly elevated in RPMI-8226/ TP-110 cells. This indicates that resistance in RPMI-8226/ TP-110 cells is involved in the expression of P-glycoprotein, a drug-efflux pump.
|
Authors | Masatomi Iijima, Isao Momose, Daishiro Ikeda |
Journal | Bioscience, biotechnology, and biochemistry
(Biosci Biotechnol Biochem)
Vol. 74
Issue 9
Pg. 1913-9
( 2010)
ISSN: 1347-6947 [Electronic] England |
PMID | 20834157
(Publication Type: Journal Article)
|
Chemical References |
- 1-naphthylacetyl-(O-methyl)-tyrosyl-valyl-(O-methyl)-tyrosinal
- ABCB1 protein, human
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antineoplastic Agents
- Oligopeptides
- Proteasome Inhibitors
- Verapamil
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(analysis, biosynthesis)
- Antineoplastic Agents
(pharmacology)
- Drug Resistance, Neoplasm
(drug effects, genetics)
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Inhibitory Concentration 50
- Multiple Myeloma
(chemistry, drug therapy, metabolism)
- Oligopeptides
(pharmacology)
- Proteasome Inhibitors
- Tumor Cells, Cultured
- Verapamil
(pharmacology)
|